CME COURSE: TYPE O NEGATIVE RED BLOOD CELL UTILIZATION: PRESERVING THIS RARE AND LIFESAVING RESOURCE

Type O negative blood – every hospital wants a supply on its shelves. But with a prevalence of only seven percent within the population, this valuable resource must be managed with care. Dr. Mair will discuss ways to best utilize lifesaving type O negative red blood cells.


TARGET AUDIENCE / PREREQUISITES

This activity has been designed for general, specialty and subspecialty physicians who prescribe blood products and for hospital transfusion service Medical Directors. There are no participant prerequisites for this activity.

CONTINUING CERTIFICATION CATEGORY: Medical Knowledge

CME CREDITS: 1.0 AMA PRA Category 1 Credit(s)TM

Enter Course


LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Identify O RhD– patients who are at lower risk for making an anti-D antibody after receiving O RhD+ red cells
  2. Describe ways to preserve the supply of O RhD- red cells for patients who need them
  3. Apply knowledge of AABB standards to providing RhD+ cellular products to RhD– patients

LEARNING TASKS
To receive CME credit for this activity, participants must:

  1. Acknowledge their review of activity prerequisites, objectives, disclosures, methods of physician participation and statements.
  2. Review the presentation "Type O Negative Red Blood Cell Utilization: Preserving this Rare and Lifesaving Resource" or read the PowerPoint slides and accompanying notes available as a printable Adobe Reader® file.
  3. Take the online Post-Test.
  4. Complete the online Activity Evaluation.
  5. Print the certificate awarding 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESSTM program.

FACULTY
David C. Mair, M.D.
Chief Medical Officer
West Blood Services Division of the American Red Cross
St. Paul, MN

ACTIVITY PLANNER
Liz Marcus
Director, Hospital Sales and Marketing
Biomedical Services, American Red Cross
Washington, DC

DISCLOSURES
Dr Mair has indicated that he has no relevant financial relationships with commercial interests to disclose. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity meets the American Board of Pathology (ABP) Continuing Certification (CC) for Self-Assessment Modules (SAMs).

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 75% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

UPDATED COURSE RELEASE DATE: 03/08/2018

EXPIRATION DATE: 03/07/2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour(s)

Last modified: Friday, July 12, 2019, 05:02 PM